View More Recent Stories

Jul 9, 2024 07:00PM 2Q24 U.S. biotech earnings preview
Jul 8, 2024 10:54AM Alnylam Pharmaceuticals (ALNY) PT Raised to $357 at Canaccord Genuity
Jun 28, 2024 05:18AM Alnylam Pharmaceuticals (ALNY) PT Raised to $288 at UBS
Jun 27, 2024 08:10AM Alnylam Pharmaceuticals (ALNY) PT Raised to $295 at Stifel
Jun 27, 2024 06:12AM Alnylam Pharmaceuticals (ALNY) PT Raised to $265 at RBC Capital, 'we remain buyers'
Jun 25, 2024 10:32AM Increasing unusual call option volume: ALNY ZI MCRB BURL FTAI BRCC ENVX OLLI
Jun 25, 2024 10:22AM Alnylam Pharmaceuticals (ALNY) PT Raised to $282 at TD Cowen
Jun 25, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Jun 24, 2024 12:28PM Alnylam Pharmaceuticals (ALNY) PT Raised to $250 at Morgan Stanley
Jun 24, 2024 12:03PM Midday movers: Apple, Eli Lilly rise; Coinbase falls
Jun 24, 2024 11:41AM TD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Jun 24, 2024 11:38AM RBC Capital Positive on Alnylam Pharmaceuticals (ALNY): 'HELIOS-B Hits Convincingly Across the Board, Materially Exceeding Expectations'
Jun 24, 2024 11:20AM Alnylam Pharma (ALNY) out of the money July puts and January 260 calls active as share price up 38%
Jun 24, 2024 07:58AM Alnylam (ALNY) data is positive for Ionis (IONS), Intellia (NTLA) and negative for BridgeBio (BBIO) - analyst
Jun 24, 2024 07:52AM BMO Capital Reiterates Outperform Rating on Alnylam (ALNY), Sees Significant Upside Following Data
Jun 24, 2024 07:28AM Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Jun 24, 2024 07:27AM Alnylam Pharma (ALNY) Reports Positive Topline Results from HELIOS-B Phase 3 Study of Vutrisiran
Jun 24, 2024 07:11AM Alnylam Pharma (ALNY) to Resume Trading at 7:30 a.m.
Jun 24, 2024 07:10AM BridgeBio Pharma (BBIO) Trades Lower After Alnylam Pharma (ALNY) Reports Positive Data
Jun 12, 2024 06:12AM RBC Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
Mar 17, 2024 08:00PM Top pharma stocks to own in 2024 – Citi
View More Recent Stories